InMode (INMD) Cash & Equivalents (2018 - 2026)

InMode (INMD) posted quarterly Cash & Equivalents of $394.3 million for Q1 2026, up 170.16% year-on-year from $145.9 million in Q1 2025, and up 30.33% on a QoQ basis from $302.5 million in Q4 2025.

InMode (INMD) Cash & Equivalents (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Cash & Equivalents for 9 consecutive years, with $394.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Equivalents rose 170.16% year-over-year to $394.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $394.3 million (up 170.16% YoY) and the FY2025 annual result came in at $302.5 million, up 94.78% from the prior year.
  • Cash & Equivalents rose to $394.3 million in Q1 2026 per INMD's latest filing, from $302.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for INMD reached as high as $394.3 million in Q1 2026 and fell as low as $44.7 million in Q1 2022.
  • A 5-year average of $157.8 million and a median of $144.4 million in 2023 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents plunged 42.45% — and 2026, when it soared 170.16%.
  • Year by year, Cash & Equivalents stood at $97.5 million in 2022, then soared by 48.05% to $144.4 million in 2023, then climbed by 7.56% to $155.3 million in 2024, then jumped by 94.78% to $302.5 million in 2025, then surged by 30.33% to $394.3 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $394.3 million, $302.5 million, and $252.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 6.80 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 2.88 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.95 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.45 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1.12 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.03 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.29 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 557.00 Mn
10 InMode 956,721.10 -479.17 Mn 61.55 Mn 394.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 394.30 Mn
Dec 31, 2025 302.54 Mn
Sep 30, 2025 252.44 Mn
Jun 30, 2025 216.24 Mn
Mar 31, 2025 145.95 Mn
Dec 31, 2024 155.33 Mn
Sep 30, 2024 164.84 Mn
Jun 30, 2024 92.00 Mn
Mar 31, 2024 120.93 Mn
Dec 31, 2023 144.41 Mn
Sep 30, 2023 133.73 Mn
Jun 30, 2023 159.86 Mn
Mar 31, 2023 92.96 Mn
Dec 31, 2022 97.54 Mn
Sep 30, 2022 77.05 Mn
Jun 30, 2022 88.40 Mn
Mar 31, 2022 44.67 Mn
Dec 31, 2021 68.14 Mn
Sep 30, 2021 68.93 Mn
Jun 30, 2021 61.77 Mn